Galicia-Garcia U.,Benito-Vicente A.,Jebari S.,Larrea-Sebal A.,Siddiqi H.,Uribe K. B.,Ostolaza H.,C. H. .2020 .Pathophysiology of type 2 diabetes mellitus. International journal of molecular sciences, 21(17) : 6275.
Sudesna C.,Khunti K.,Davies M. J. .2017 .. Type 2 diabetes. The Lancet, 389(10085) : 2239-2251.
AlSaraj F. .2015 .Pathogenesis of type 2 diabetes mellitus. In Treatment of Type 2 Diabetes, : .
Roden M.,Shulman G. I. . .The integrative biology of type 2 diabetes.. , : .
.2019 .. Nature, 576(7785) : 51-60.
B. .2018 .Type 2 diabetes. The Lancet, 391(10127) : 1261.
Ma Q.,Li Y.,Wang M.,Tang Z.,Wang T.,Wang C.,Zhao C.,B. C. .1834 .Progress in metabonomics of type 2 diabetes mellitus. Molecules, 23(7) : .
Wu Y.,Ding Y.,Tanaka Y.,W. Y. . .Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. , : .
.2014 .. International journal of medical sciences, 11(11) : 1185.
Giacco F.,Brownlee M. .2010 .. Circ. Res, 107 : 1058-1070.
Astiarraga B.,Chueire V. B.,Souza A. L.,Pereira-Moreira R.,Natali S.,Tura A.,Mari A.,Ferrannini A.,Muscelli E.,E. E. . .Effects of acute NEFA manipulation on incretin-induced insulin secretion in participants with and without type 2 diabetes.. , : .
.2018 .. Diabetologia, 61(8) : 1829-1837.
Vona R.,Cittadini L.,Straface C.,Pietraforte E.,D. E. .2019 .Biomarkers of oxidative stress in metabolic syndrome and associated diseases. Oxidative medicine and cellular longevity, : .
Lopez M. J.,Royer A.,Shah N. J. .2021 .. , : .
Frieden E.,Hsieh H. S. .1976 .Ceruloplasmin: the copper transport protein with essential oxidase activity. Adv Enzymol Relat Areas Mol Biol, 44 : 187-236.
Menzel A.,Samouda H.,Dohet F.,Loap S.,M. S. S.,T. S. .2021 .Common and novel markers for measuring inflammation and oxidative stress ex vivo in research and clinical practice-Which to use regarding disease outcomes. Antioxidants, 10(3) : 414.
White C. A.,Kennedy J. F.,Carbohydrates J. F. . .. volume VI: Metabolites, 1 : .
Bergmeyer and M. GraRl .1985 .. 00;seriessubscriptionprice 130.00, DM 295.00. ISBN 3‐527‐26046‐3, (DM350) : .
Tietz N. W. .2006 .Tietz Clinical guide to laboratory tests. , : .
Draper H. H.,M. H. H. .1990 .Malondialdehyde determination as index of lipid Peroxidation. , 186 : 421-431.
Rice E. W. .1962 .Standardization of ceruloplasmin activity in terms of international enzyme units: Oxidative formation of “Bandrowski's base” from p-phenylenediamine by ceruloplasmin. Analytical biochemistry, 3(6) : 452-456.
.1951 .Coeruloplasmin as an enzyme. Aeta chem. scand. 5, (195t) : .
.1998 .. Clinical chemistry, 44(11) : 2313-2319.
Mandal M.,Varghese A.,Gaviraju V.,Talwar S. N.,Malini S. S. .2019 .Impact of hyperglycaemia on molecular markers of oxidative stress and antioxidants in type 2 diabetes mellitus. Clinical Diabetology, 8(4) : 215-222.
Sharma M.,Bhatia K.,Misra P.,Ambade S.,Mukherjee V. N.,B. V. N. . .A STUDY OF PLASMA GLUCOSE AND SERUM CERULOPLASMIN IN TYPE-2 DIABETES MELLITUS (T2DM) AT A TERTIARY CARE HOSPITAL. , : .
Sharma V. K.,Tumbapo A.,Pant V.,Aryal B.,Shrestha S.,Yadav B. K.,Tuladhar E. T.,Bhattarai A.,Raut M.,Ceruloplasmin M. . .. , 24 : .
.2018 .potential marker for glycemic status and its relationship with lipid profile in Type II diabetes mellitus. Asian Journal of Medical Sciences, 9(2) : 13-18.
Al-Hmmamy S.,Najaf AL,Governorate AL,Batra N.,H. S. N.,Gupta M.,Mahindra S.,V. S. .2013 .Evaluation of Serum Ceruloplasmin Levels as a Biomarker for Oxidative Stress in Patients With Diabetic Retinopathy. No. (7), : .
.2021 .. Cureus, 13(2) : .
Shukla N.,Maher J.,Masters J.,Jeremy G. D.,J. Y. G. D. .2006 .Does oxidative stress change ceruloplasmin from a protective to a vasculopathic factor?. Atherosclerosis, 187(2) : 238-250.
Arenas de Larriva A. P.,Limia-Pérez L.,Alcalá-Díaz J. F.,Alonso A.,López-Miranda J.,Delgado-Lista J. .2020 .. Ceruloplasmin and Coronary Heart Disease-A Systematic Review. Nutrients, 12(10) : 3219.
Voynova I. V.,Kostevich V. A.,Elizarova A. Y.,Karpenko M. N.,Sokolov A. V. . .The specific activity of proteins involved in iron metabolism depends on compensation of type 2 diabetes mellitus. , : .
.2019 .. Medical academic journal, 19(2) : 37-42.
Sacheat H.,Al-Mudhaffar S.,S. S. .2021 .In Evaluation of Ceruloplasmin ferroxidase activity and lipid profiles in patients with Valvular heart diseases. Journal of Physics: Conference Series, : 022066.